Stay updated on GLPG2222 in Ivacaftor-treated CF: Clinical Trial

Sign up to get notified when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer changes include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T12:33:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    PubMed publications section text was updated to state that items are automatically filled from PubMed and may not be about the study. The page revision note was updated to Revision: v3.3.2, replacing the previous v3.2.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:07:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and operating status; this does not affect the study details, eligibility, outcomes, or primary purpose of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:05:24.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    No significant core content changes were detected; the study title, conditions, inclusion/exclusion criteria, and location lists remain as shown, with only minor formatting variations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:28:55.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Updated operating status notice and version from v3.1.0 to v3.2.0; clarifies potential delays in processing and directs users to official status sources. If no other substantial content changes are present, this is a partial but meaningful update to core page messaging.
    Difference
    4%
    Check dated 2025-10-05T10:28:24.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-28T03:21:46.000Z thumbnail image

Stay in the know with updates to GLPG2222 in Ivacaftor-treated CF: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.